Patent details

LUC00237 Product Name: duvelisib

Basic Information

Publication number:
LUC00237
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP108001751
Legal Status:
Inactive
Application number:
LUC00237
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU1/21/1542
Marketing Authorization Type:
Marketing Authorization Date:
21/05/2021
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
03/11/2021
First Marketing Authorization date:
21/05/2021
Grant date:
03/02/2025
Activation date:
Publication date:
03/11/2021
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
15/07/2035
SPC Extension Expiration:
15/07/2035
Rejection date:
Withdrawal date:

Owner

From:
03/11/2021
 
 

Name:
Intellikine LLC
Address:
10931 North Torrey Pines Road, Suite 103, La Jolla CA 92037, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
03/11/2021
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2021/13
Publication date:
02/12/2021
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2025/04
Publication date:
04/03/2025
Description:
Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:
31/07/2030
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
03/11/2021 Application Form 3
03/11/2021 Outgoing Correspondence 1
03/11/2021 Marketing authorization 3
03/11/2021 MA publication 7
03/11/2021 Summary of the product caracteristics 44
03/11/2021 Publication 1
03/02/2025 Publication 1
03/02/2025 Certificate 1
03/02/2025 Outgoing Correspondence 1